This study has been completed. The goal of the Phase I part of this clinical research study is to find the highest tolerable dose of a combination of dasatinib, cetuximab, and FOLFOX (5-fluorouracil [5-FU], leucovorin [LV], and Eloxatin [oxaliplatin]) that can be given to patients with metastatic colorectal cancer. The safety of these drugs in combination will also be studied.
Shingles is a painful, usually blistering skin rash typically found on one side of the body, wrapping around the trunk or waist. But it can appear anywhere from the head, arms, chest, abdomen or buttocks down to the feet.
Symptoms of shingles include an itchy, painful rash that forms blisters on one side of the body. They can also, in rarer cases, cause severe complications, like changes in vision and hearing, or pain lasting up to several years after the shingles rash is gone.